Key result
Maternal allopurinol prevents hypoxic pregnancy-induced cardiac dysfunction in adult offspring.
Answers are grounded in this paper and cite their sources.
Demonstrates that maternal allopurinol prevents hypoxia-induced cardiac dysfunction and injury in adult male rat offspring, indicating xanthine oxidase as a therapeutic target.
Integrating functional and molecular levels, we investigated the effects of maternal treatment with a xanthine oxidase inhibitor on the programming of cardiac dysfunction in adult offspring using an established rat model of hypoxic pregnancy. Female Wistar rats were divided into normoxic or hypoxic (13% O 2 ) pregnancy±maternal allopurinol treatment (30 mg kg -1 d -1 ). At 4 months, hearts were isolated from 1 male per litter per outcome variable to determine cardiac function and responses to ischemia-reperfusion in a Langendorff preparation. Sympathetic dominance, perfusate CK (creatine kinase) and LDH (lactate dehydrogenase) and the cardiac protein expression of the β 1 -adrenergic receptor, the M 2 Ach receptor (muscarinic type-2 acetylcholine receptor), and the SERCA2a (sarcoplasmic reticulum Ca 2+ ATPase 2a) were determined. Relative to controls, offspring from hypoxic pregnancy showed elevated left ventricular end diastolic pressure (+34.7%), enhanced contractility (dP/dt max , +41.6%), reduced coronary flow rate (−21%) and an impaired recovery to ischemia-reperfusion (left ventricular diastolic pressure, area under the curve recovery −19.1%; all P <0.05). Increased sympathetic reactivity (heart rate, +755.5%; left ventricular diastolic pressure, +418.9%) contributed to the enhanced myocardial contractility ( P <0.05). Perfusate CK (+431%) and LDH (+251.3%) and the cardiac expression of SERCA2a (+71.4%) were also elevated ( P <0.05), further linking molecular markers of cardiac stress and injury to dysfunction. Maternal allopurinol restored all functional and molecular indices of cardiac pathology. The data support a link between xanthine oxidase–derived oxidative stress in hypoxic pregnancy and cardiac dysfunction in the adult offspring, providing a target for early intervention in the developmental programming of heart disease.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2018) studied Cardiac dysfunction programmed by chronic hypoxic pregnancy (rat model). Maternal allopurinol vs. Untreated normoxic or hypoxic (13% O2) pregnancy was evaluated on Functional and molecular indices of cardiac dysfunction and ischemia-reperfusion recovery (including LVEDP, dP/dtmax, coronary flow rate, CK, LDH, and SERCA2a) (p=<0.05). Maternal allopurinol restored cardiac dysfunction in adult rat offspring from hypoxic pregnancy, which otherwise elevated LVEDP and dP/dtmax.
Synapse has enriched 10 related papers. Consider them for comparative context: